The MUC5B promoter risk allele for idiopathic pulmonary fibrosis predisposes to asbestosis

Asbestosis is a fibrosing interstitial pneumonitis, which can develop following occupational asbestos exposure and a lengthy latency period [1]. Even after strict regulations on the asbestos industry, an estimated 3400 individuals worldwide died as a consequence of asbestosis in 2017 [2]. Footnotes This manuscript has recently been accepted for publication in the European Respiratory Journal . It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Please open or download the PDF to view this article. Conflict of interest: Dr Platenburg has nothing to disclose. Conflict of interest: Dr Wiertz has nothing to disclose. Conflict of interest: Dr van der Vis has nothing to disclose. Conflict of interest: Dr Crestani has nothing to disclose. Conflict of interest: Dr Borie reports grants and personal fees from Roche, grants and personal fees from Boerhinger Ingelheim, outside the submitted work. Conflict of interest: Philippe Dieude Conflict of interest: Dr Kannengiesser has nothing to disclose. Conflict of interest: D. Burgers reports grants from MSD, other from Roche, other from AstraZeneca, other from Boehringer Ingelheim, outside the submitted work. Conflict of interest: Dr Grutters has nothing to disclose. Conflict of interest: Dr van Moorsel has nothing to disclose.